Female sexual dysfunction in androgenetic alopecia: Case-control study

Area of Science:

• Reproductive Health
• Dermatology
• Endocrinology

Background:

• Female sexual dysfunction (FSD) is a prevalent concern affecting premenopausal women's quality of life.
• Androgenetic alopecia (AGA) and metabolic syndrome (MetS) are common conditions in women, with potential systemic implications.

Purpose of the Study:

• To investigate the association between FSD and the presence of AGA and MetS in premenopausal women.
• To identify key factors influencing sexual function in this demographic.

Main Methods:

• A prospective case-control study involving 212 premenopausal women (115 with AGA, 97 controls).
• Assessment included comprehensive history, anthropometric measurements, and the Female Sexual Function Index (FSFI).
• AGA was graded using Ludwig's classification, and MetS was diagnosed per NCEP-ATP III criteria.

Main Results:

• Univariate analysis revealed associations between FSD and age, BMI, AGA, MetS, and testosterone levels.
• Logistic regression identified age (OR 1.21), AGA (OR 3.42), MetS (OR 5.39), and free testosterone (OR 0.18) as independent predictors of FSD.
• Higher odds of FSD were associated with increasing age, AGA, and MetS, while higher free testosterone showed a protective association.

Conclusions:

• Age, androgenetic alopecia, metabolic syndrome, and free testosterone levels are significantly associated with female sexual dysfunction in premenopausal women.
• These findings highlight potential interconnections between dermatological, metabolic, and sexual health.
• Further population-based, longitudinal studies are warranted to confirm these associations.